Potential weight loss benefits Both semaglutide and tirzepatide promote weight loss , but the latter has demonstrated superior results in clinical trials
Eli Lilly, the maker of Mounjaro and Zepbound, said Thursday that the company's new orforglipron pill can offer up to an average of 27.3 pounds of weight loss, according to results from the first of two of its Phase 3 trials that included more than 3,100 overweight or obese adults
(Be careful not to make it too heavy!) Bake at 375 for 7-10 minutes
It also carries a risk of bradyarrhythmias in patients recovering from acute MI (28)(29)
However, lower doses of vitamin D and calcium, 10 g and 1000 mg per day, respectively, have shown the same outcomes in people older than 65 years [149, 150]